« Back
Home /
Cap-dependent endonuclease-IN-23

Cap-dependent endonuclease-IN-23

Item no.	HY-144067-100mg
Manufacturer	MedChem Express
CASRN	2741952-36-1
Amount	100 mg
Quantity options	100 mg 1 ea
Category	Reagents & Chemicals Biochemicals
Type	Chemicals
Specific against	other
Citations	[1]Shuhui Chen, et al. Fused ring derivatives and their pharmaceutical applications. Patent WO2021233302A1.
Smiles	CN1[C@]2([H])N(N3C(C1=O)=C(C(C=C3)=O)OCOC(OC)=O)[C@](C4=CC=CC=C4)([H])C5=CC(F)=C(F)C=C5OCC2
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	COVID-19-anti-virus
Manufacturer - Targets	Influenza Virus
Shipping Temperature	Room temperature
Molecular Weight	527.47
Product Description	Cap-dependent endonuclease-IN-23 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-23 inhibits the replication of influenza virus. ap-dependent endonuclease-IN-23 has the potential for the research of influenza virus infection (influenza A) (extracted from patent WO2021233302A1, compound 8A or 8B)[1].
Manufacturer - Research Area	Infection
Solubility	10 mM in DMSO
Manufacturer - Pathway	Anti-infection
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question